Clinical and histological features of autoantibody-negative autoimmune hepatitis in Chinese patients: A single center experience

Journal of Digestive Diseases

Volumn 14, Issue 4, 2013, Pages 175-180

  Wang, Qi Xia ^a,b   Jiang, Wei Jun ^a   Miao, Qi ^a,b   Xiao, Xiao ^a,b   Zhang, Hai Yan ^a,b   Huang, Shan Shan ^a,b   Shen, Lei ^a,b   Hua, Jing ^a,b   Li, Hai ^a,b   Li, Shen ^a,b   Qiu, De Kai ^a,b   Ma, Xiong ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Autoantibody; Autoimmune hepatitis; Immunosuppressant; Prognosis

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; IMMUNOGLOBULIN G; PREDNISOLONE;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CHINESE; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875580692     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/1751-2980.12022     Document Type: Article

References (16)

1. Manns MP, Czaja AJ, Gorham JD etal; American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis. Hepatology 2010; 51: 2193-2213.
2. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006; 354: 54-66.
3. Heneghan MA, McFarlane IG. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 2002; 35: 7-13.
4. Lohse AW, Wiegard C. Diagnostic criteria for autoimmune hepatitis. Best Pract Res Clin Gastroenterol 2011; 25: 665-671.
5. Czaja AJ. Autoantibody-negative autoimmune hepatitis. Dig Dis Sci 2012; 57: 610-624.
6. Alvarez F, Berg PA, Bianchi FB etal. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
7. Hennes EM, Zeniya M, Czaja AJ etal; International Autoimmune Hepatitis Group. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169-176.
8. Czaja AJ, Freese DK; American Association for the Study of Liver Disease. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36: 479-497.
9. Schramm C, Weiler-Normann C, Wiegard C, Hellweg S, Müller S, Lohse AW. Treatment response in patients with autoimmune hepatitis. Hepatology 2010; 52: 2247-2248.
10. Lohse AW, Mieli-Vergani G. Autoimmune hepatitis. J Hepatol 2011; 55: 171-182.
11. Bogdanos DP, Mieli-Vergani G, Vergani D. Autoantibodies and their antigens in autoimmune hepatitis. Semin Liver Dis 2009; 29: 241-253.
12. Qiu D, Wang Q, Wang H etal. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients. J Hepatol 2011; 54: 340-347.
13. Miyake Y, Iwasaki Y, Kobashi H etal. Clinical features of antinuclear antibodies-negative type 1 autoimmune hepatitis. Hepatol Res 2009; 39: 241-246.
14. Lüth S, Herkel J, Kanzler S etal. Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis. J Clin Gastroenterol 2008; 42: 926-930.
15. Wang Q, Qiu D, Ma X. Early normalisation of aminotransferase predicts complete biochemical remission in autoimmune hepatitis patients. Aliment Pharmacol Ther 2011; 34: 107-109.
16. Kanzler S, Löhr H, Gerken G, Galle PR, Lohse AW. Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. Z Gastroenterol 2001; 39: 339-341, 344-8.